Skip to main content

TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.


AUTHORS

Glaser ZA , Love HD , Guo S , Gellert L , Chang SS , Herrell SD , Barocas DA , Penson DF , Cookson MS , Clark PE , . Urologic oncology. 2017 1 17; ().

ABSTRACT

Our aims were to determine if targeting protein for Xklp2 (TPX2) is correlated with clear cell renal cell carcinoma (ccRCC) histology and oncologic outcomes using The Cancer Genome Atlas (TCGA) and an institutional tissue microarray (TMA).


Our aims were to determine if targeting protein for Xklp2 (TPX2) is correlated with clear cell renal cell carcinoma (ccRCC) histology and oncologic outcomes using The Cancer Genome Atlas (TCGA) and an institutional tissue microarray (TMA).


Tags: